Literature DB >> 23425566

Temporal lobe epilepsy exacerbation during pharmacological inhibition of endogenous neurosteroid synthesis.

Matteo Pugnaghi1, Giulia Monti, Giuseppe Biagini, Stefano Meletti.   

Abstract

We report the case of a woman who presented cryptogenic temporal lobe seizures from the age of 43 years. Antiepileptic drug (AED) treatment with carbamazepine was able to control seizures for 1 year, but seizures relapsed and an add-on treatment with lamotrigine was started without achieving seizures control. The patient's medical history was unremarkable except for a mild hirsutism for which she was taking finasteride since 45 years of age. In view of the possible relationship between finasteride, a known inhibitor of neurosteroids synthesis, and patient's seizures exacerbation, we stopped finasteride resulting in prompt recovery of seizures control. It is know that 5α-dihydrosteroids are precursors of powerful positive modulators of γ-aminobutyric acid-A inhibitory currents and exert antiseizure effects in animal epilepsy models. This case supports the hypothesis that endogenous neurosteroids can modulate seizure susceptibility and response to AEDs also in humans, suggesting their possible use as a new therapeutic option.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23425566      PMCID: PMC3604425          DOI: 10.1136/bcr-2012-008204

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

1.  Ovarian cycle-linked changes in GABA(A) receptors mediating tonic inhibition alter seizure susceptibility and anxiety.

Authors:  Jamie L Maguire; Brandon M Stell; Mahsan Rafizadeh; Istvan Mody
Journal:  Nat Neurosci       Date:  2005-05-15       Impact factor: 24.884

Review 2.  Neurosteroids: endogenous regulators of the GABA(A) receptor.

Authors:  Delia Belelli; Jeremy J Lambert
Journal:  Nat Rev Neurosci       Date:  2005-07       Impact factor: 34.870

3.  Neurosteroid withdrawal regulates GABA-A receptor α4-subunit expression and seizure susceptibility by activation of progesterone receptor-independent early growth response factor-3 pathway.

Authors:  O Gangisetty; D S Reddy
Journal:  Neuroscience       Date:  2010-07-27       Impact factor: 3.590

4.  Endogenous neurosteroid synthesis modulates seizure frequency.

Authors:  Courtney Lawrence; Brandon Scott Martin; Chengsan Sun; John Williamson; Jaideep Kapur
Journal:  Ann Neurol       Date:  2010-05       Impact factor: 10.422

5.  Endogenous neurosteroids modulate epileptogenesis in a model of temporal lobe epilepsy.

Authors:  Giuseppe Biagini; Enrica Baldelli; Daniela Longo; Luca Pradelli; Isabella Zini; Michael A Rogawski; Massimo Avoli
Journal:  Exp Neurol       Date:  2006-06-14       Impact factor: 5.330

6.  Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study.

Authors:  Matti Sillanpää; Dieter Schmidt
Journal:  Brain       Date:  2006-01-09       Impact factor: 13.501

7.  Seizure exacerbation associated with inhibition of progesterone metabolism.

Authors:  Andrew G Herzog; Cheryl A Frye
Journal:  Ann Neurol       Date:  2003-03       Impact factor: 10.422

Review 8.  Neurosteroids and epilepsy.

Authors:  Giuseppe Biagini; Gabriella Panuccio; Massimo Avoli
Journal:  Curr Opin Neurol       Date:  2010-04       Impact factor: 5.710

Review 9.  The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy.

Authors:  Doodipala Samba Reddy
Journal:  Epilepsy Res       Date:  2009-04-29       Impact factor: 3.045

10.  Finasteride inhibits the disease-modifying activity of progesterone in the hippocampus kindling model of epileptogenesis.

Authors:  Doodipala Samba Reddy; G Ramanathan
Journal:  Epilepsy Behav       Date:  2012-07-24       Impact factor: 2.937

View more
  4 in total

1.  Neurosteroids modulate epileptiform activity and associated high-frequency oscillations in the piriform cortex.

Authors:  R Herrington; M Lévesque; M Avoli
Journal:  Neuroscience       Date:  2013-10-21       Impact factor: 3.590

Review 2.  Neurosteroids and Focal Epileptic Disorders.

Authors:  Maxime Lévesque; Giuseppe Biagini; Massimo Avoli
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

Review 3.  Experimental GABA A Receptor Agonists and Allosteric Modulators for the Treatment of Focal Epilepsy.

Authors:  Slobodan M Janković; Miralem Dješević; Snežana V Janković
Journal:  J Exp Pharmacol       Date:  2021-03-08

4.  Role of hormones and neurosteroids in epileptogenesis.

Authors:  Doodipala Samba Reddy
Journal:  Front Cell Neurosci       Date:  2013-07-31       Impact factor: 5.505

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.